# Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata

> **NCT01797432** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 14 (actual)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10)
- **DEVICE:** Restylane

## Key facts

- **NCT ID:** NCT01797432
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2014-11
- **Final completion:** 2015-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2021-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01797432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01797432, "Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01797432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*